Additional Content Download
Pharma IQ in conjunction with the 8th Annual Global Biobanking prepared this Global Guide to Biobanking, the definitive resource for professionals in the biobanking area. The guide summarizes the key issues related to new disposable solutions in biomanufacturing, current failures and new models of consent and recent commercial and technological trends in biobanking area.
This presentation examines the use of digital dispense technology within a screening environment, demonstrates the dispense of a large set of compounds using the Digital dispense technology, looks at the use of the Acoustic technology within GSK and describes the dispense of non-DMSO solutions in low volume.
This presentation looks at this from small molecules to peptides, from single stock concentration to project specific concentration, from site-based model to global/CRO support and ensure quality with sample QC.
We spoke with James Brennan, Informatics Lead at the UK Biocentre about integrating their sample ordering system with an existing LIMS. We also spoke about the challenges involved in a sample ordering system; such as large scale ordering and ensuring the correct spread with regard to sample attributes.
Jon Wetzel, founder of the Lean for Everyone blog, joins Andrea Charles from Pharma IQ to discuss recent technological and commercial trends in the biobanking sector. Pharma IQ: What technological and commercial trends have you seen in the biobanking sector recently? J Wetzel: I think we’ve seen a slow shift from the big experiment to the smaller, discrete datasets that are more cus.... Learn more
We spoke to Kathi Shea, former President of ISBER and Vice President BioServices, Precision for medicine. Kathi spoke about procedures and training increase the value of samples and data being collected and also gave us her key to comprehensive planning.
Inside Development of Lundbeck’s Inhouse Global Compound Management and Compound Ordering System - An Interview with Claus Stie Kallesøe
Creating a fit-for-purpose compound management and compound ordering system is a huge task, so often the best way to understand is to look at those who have done it before. We spoke to Claus Stie Kallesøe, Head of Research Informatics at Lundbeck about his experiences in this task and how it was completed from inception to completion. Claus also describes the challenges involved and how flexible a system has to be to deal with all that is expected of it from compound ordering to dealing with multiple data sources.
The Road To ‘Personalised Medicine’ and the rules of good biobanking with AstraZeneca's Duncan McHale, Vice-President for Personalised Healthcare and Biomarkers
Duncan McHale, Vice-President for Personalised Healthcare and Biomarkers, Astrazeneca, joins Helen Winsor of Pharma IQ. In this interview he discusses the importance of biomarker discovery & validation, how close we are to ‘Personalised Medicine’, why sample quality is key, the rules of good biobanking, how we can improve biomarker research, what we should change and why, what’s stopping us bringing change and his top 3 priorities for the next 12 months.